Eliminating microscopic lymph node metastasis by performing pelvic lymph node dissection during radical prostatectomy for prostate cancer

被引:4
作者
Furubayashi, Nobuki [1 ]
Negishi, Takahito [1 ]
Uozumi, Tomoharu [1 ]
Shiraishi, Kouichi [1 ]
Taguchi, Kenichi [2 ]
Shimokawa, Mototsugu [3 ]
Nakamura, Motonobu [1 ]
机构
[1] Natl Hosp Org, Dept Urol, Kyushu Canc Ctr, Fukuoka 8111395, Japan
[2] Natl Hosp Org, Dept Pathol, Kyushu Canc Ctr, Fukuoka 8111395, Japan
[3] Natl Hosp Org, Inst Clin Res, Kyushu Canc Ctr, Fukuoka 8111395, Japan
关键词
prostate cancer; radical prostatectomy; microscopic lymph node metastases; pelvic lymph node dissection; prostate-specific antigen failure; NATURAL-HISTORY; LYMPHADENECTOMY; PROGRESSION; SURVIVAL; THERAPY; DISEASE; CHANCE;
D O I
10.3892/mco.2019.1965
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The oncological benefit of pelvic lymph node dissection (PLND) for prostate cancer (PCa) remains unclear. The therapeutic effect of PLND on the elimination of microscopic metastases during radical prostatectomy (RP) for PCa was examined in the current study. A total of 348 Japanese patients with high- or intermediate-risk PCa without lymph node metastasis, who underwent antegrade RP at the Kyushu Cancer Center (Fukuoka, Japan) between August 1998 and May 2013 were retrospectively analyzed. The patients were divided into the standard (obturator + internal iliac nodes) group and the expanded (standard + additional nodes) group according to the extent of PLND. Preoperative and postoperative characteristics were also analyzed to determine the factors associated with prostate-specific antigen (PSA) failure. Standard and expanded PLND were performed in 70.9% (247/348) and 29.1% (101/348) of cases, respectively. The results revealed that preoperative PSA levels were the only marked difference between the two groups. No differences were observed in the other preoperative and postoperative characteristics. Furthermore, the rate of PSA recurrence in each group did not differ to a statistically significant extent (P=0.3622). Reducing the area of dissection from expanded PLND to standard PLND significantly reduced the number of dissected lymph nodes (P<0.0001). Additionally, the PSA level, clinical tumor stage, Gleason score of the biopsy specimen, pathological tumor stage and extent of PLND were all associated with PSA recurrence, as determined via multivariate Cox hazards regression analysis (P=0.0177, P=0.0023, P=0.0027, P<0.0001 and P=0.0164, respectively). In high- and intermediate-risk patients without lymph node metastasis, a greater number of lymph nodes were dissected when the extent of dissection was greater. Furthermore, the extent of PLND was a significantly associated with PSA failure. The results indicated that PLND exerted a therapeutic effect by eliminating microscopic pelvic lymph node metastases that were not detected by routine pathological examinations.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 23 条
[1]  
[Anonymous], 2009, UICC INT UNION CANC
[2]  
[Anonymous], GUIDELINES PROSTATE
[3]   Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? [J].
Bader, P ;
Burkhard, FC ;
Markwalder, R ;
Studer, UE .
JOURNAL OF UROLOGY, 2003, 169 (03) :849-854
[4]   Pelvic Lymph Node Dissection in Prostate Cancer: The Mystery Is Taking Shape [J].
Briganti, Alberto ;
Suardi, Nazareno ;
Gallina, Andrea ;
Abdollah, Firas ;
Montorsi, Francesco .
EUROPEAN UROLOGY, 2013, 63 (03) :459-461
[5]   Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection [J].
Briganti, Alberto ;
Abdollah, Firas ;
Nini, Alessandro ;
Suardi, Nazareno ;
Gallina, Andrea ;
Capitanio, Umberto ;
Bianchi, Marco ;
Tutolo, Manuela ;
Passoni, Niccolo Maria ;
Salonia, Andrea ;
Colombo, Renzo ;
Freschi, Massimo ;
Rigatti, Patrizio ;
Montorsi, Francesco .
EUROPEAN UROLOGY, 2012, 61 (06) :1132-1138
[6]   Pelvic Lymph Node Dissection in Prostate Cancer [J].
Briganti, Alberto ;
Blute, Michael L. ;
Eastham, James H. ;
Graefen, Markus ;
Heidenreich, Axel ;
Karnes, Jeffrey R. ;
Montorsi, Francesco ;
Studer, Urs E. .
EUROPEAN UROLOGY, 2009, 55 (06) :1251-1265
[7]   Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Blank, K ;
Broderick, GA ;
Tomaszewski, JE ;
Renshaw, AA ;
Kaplan, I ;
Beard, CJ ;
Wein, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :969-974
[8]   Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results [J].
Daneshmand, S ;
Quek, ML ;
Stein, JP ;
Lieskovsky, G ;
Cai, J ;
Pinski, J ;
Skinner, EC ;
Skinner, DG .
JOURNAL OF UROLOGY, 2004, 172 (06) :2252-2255
[9]   The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review [J].
Fossati, Nicola ;
Willemse, Peter-Paul M. ;
Van den Broeck, Thomas ;
van den Bergh, Roderick C. N. ;
Yuan, Cathy Yuhong ;
Briers, Erik ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Cornford, Philip ;
De Santis, Maria ;
MacPepple, Ekelechi ;
Henry, Ann M. ;
Mason, Malcolm D. ;
Matveev, Vsevolod B. ;
van der Poel, Henk G. ;
van der Kwast, Theo H. ;
Rouviere, Olivier ;
Schoots, Ivo G. ;
Wiegel, Thomas ;
Lam, Thomas B. ;
Mottet, Nicolas ;
Joniau, Steven .
EUROPEAN UROLOGY, 2017, 72 (01) :84-109
[10]  
Furubayashi N, 2017, MOL CLIN ONCOL, V6, P775, DOI 10.3892/mco.2017.1204